Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Krause AS, Weihrauch MR, Bode U, Fleischhack G, Elter T, Heuer T, Engert A, Diehl V, Josting A.

Leuk Lymphoma. 2002 Nov;43(11):2139-43.

PMID:
12533039
2.

Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.

Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC.

Cancer. 1995 Aug 1;76(3):521-6.

3.

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.

Widemann BC, Balis FM, Murphy RF, Sorensen JM, Montello MJ, O'Brien M, Adamson PC.

J Clin Oncol. 1997 May;15(5):2125-34.

PMID:
9164227
4.

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.

Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.

Cancer. 2004 May 15;100(10):2222-32.

5.

Carboxypeptidase G2 rescue in delayed methotrexate elimination in renal failure.

Mohty M, Peyriere H, Guinet C, Hillaire-Buys D, Blayac JP, Rossi JF.

Leuk Lymphoma. 2000 Apr;37(3-4):441-3.

PMID:
10752997
6.
7.

Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.

Adamson PC, Balis FM, McCully CL, Godwin KS, Poplack DG.

J Clin Oncol. 1992 Aug;10(8):1359-64.

PMID:
1634927
8.

Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure.

Zoubek A, Zaunschirm HA, Lion T, Fischmeister G, Vollnhofer G, Gadner H, Pillwein K, Schalhorn A, Bode U.

Pediatr Hematol Oncol. 1995 Sep-Oct;12(5):471-7.

PMID:
8519632
9.

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.

Buchen S, Ngampolo D, Melton RG, Hasan C, Zoubek A, Henze G, Bode U, Fleischhack G.

Br J Cancer. 2005 Feb 14;92(3):480-7.

10.

[Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].

von Poblozki A, Dempke W, Schmoll HJ.

Med Klin (Munich). 2000 Aug 15;95(8):457-60. German.

PMID:
10985069
11.

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.

Estève MA, Devictor-Pierre B, Galy G, André N, Coze C, Lacarelle B, Bernard JL, Monjanel-Mouterde S.

Eur J Clin Pharmacol. 2007 Jan;63(1):39-42. Epub 2006 Nov 18. No abstract available.

PMID:
17115148
12.

Carboxypeptidase G2 rescue after high-dose methotrexate.

DeAngelis LM, Tong WP, Lin S, Fleisher M, Bertino JR.

J Clin Oncol. 1996 Jul;14(7):2145-9.

PMID:
8683248
13.

Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.

Adamson PC, Balis FM, McCully CL, Godwin KS, Bacher JD, Walsh TJ, Poplack DG.

J Clin Oncol. 1991 Apr;9(4):670-4.

PMID:
2066764
14.

Effective removal of methotrexate by high-flux hemodialysis.

Saland JM, Leavey PJ, Bash RO, Hansch E, Arbus GS, Quigley R.

Pediatr Nephrol. 2002 Oct;17(10):825-9. Epub 2002 Aug 9.

PMID:
12376811
15.

Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC.

J Natl Cancer Inst. 2004 Oct 20;96(20):1557-9.

16.

Glucarpidase for the treatment of life-threatening methotrexate overdose.

Tuffaha HW, Al Omar S.

Drugs Today (Barc). 2012 Nov;48(11):705-11. doi: 10.1358/dot.2012.48.11.1871575. Review.

PMID:
23170306
17.

Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.

Widemann BC, Schwartz S, Jayaprakash N, Christensen R, Pui CH, Chauhan N, Daugherty C, King TR, Rush JE, Howard SC.

Pharmacotherapy. 2014 May;34(5):427-39. doi: 10.1002/phar.1360. Epub 2013 Oct 17.

18.

[The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate].

Blasco H, Silly S, Tournamille JF, Gyan E, Sénécal D, André V, Colombat P, Le Guellec C.

Therapie. 2008 Jan-Feb;63(1):19-28. doi: 10.2515/therapie:2008013. Epub 2008 Apr 4. French.

PMID:
18387272
19.

Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.

Bacci G, Ferrari S, Longhi A, Forni C, Loro L, Beghelli C, Tremosini M, Versari M.

Oncol Rep. 2003 Jul-Aug;10(4):851-7.

PMID:
12792734
20.

Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, O'Brien M, Eby M, Cole DE, Murphy RF, Fox E, Ivy P, Adamson PC.

J Clin Oncol. 2010 Sep 1;28(25):3979-86. doi: 10.1200/JCO.2009.25.4540. Epub 2010 Aug 2.

Items per page

Supplemental Content

Write to the Help Desk